| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 854,000 | 881,000 | 817,000 | 904,000 | | Cost of Revenue | 257,000 | 257,000 | 253,000 | 266,000 | | | Gross Profit | 597,000 | 624,000 | 564,000 | 638,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 338,000 | 310,000 | 281,000 | 270,000 | | Non Recurring | 256,000 | (212,000) | 3,000 | 44,000 | | Others | 40,000 | 40,000 | 38,000 | 40,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 215,000 | 486,000 | 242,000 | 284,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 258,000 | 20,000 | 8,000 | 16,000 | | Earnings Before Interest And Taxes | 38,000 | 506,000 | 250,000 | 241,000 | | Interest Expense | (117,000) | 60,000 | 57,000 | 60,000 | | Income Before Tax | 155,000 | 446,000 | 193,000 | 181,000 | | Income Tax Expense | 54,000 | 267,000 | 70,000 | 67,000 | | Minority Interest |
-
| 2,000 |
-
| (9,000) | | | | Net Income From Continuing Ops | 99,000 | 181,000 | 123,000 | 105,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 101,000 | 181,000 | 123,000 | 106,000 | | Preferred Stock And Other Adjustments | (6,000) | 2,000 | (4,000) |
-
| | | Net Income Applicable To Common Shares | $95,000 | $183,000 | $119,000 | $106,000 |
|
1.52% Nasdaq 0.00%
Income Statement
